The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials
暂无分享,去创建一个
[1] Carole Federico,et al. Consider drug efficacy before first-in-human trials , 2017, Nature.
[2] Brian Chen,et al. "Right-to-Try" Legislation: Progress or Peril? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Gillian L. Currie,et al. Systematic Review and Meta-analysis: Important Tools in Understanding Drug Development for Stroke , 2017 .
[4] G. Norman. Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs. , 2016 .
[5] S. Gopalakrishnan,et al. Systematic Reviews and Meta-analysis: Understanding the Best Evidence in Primary Healthcare , 2013, Journal of family medicine and primary care.
[6] Andrew S.C. Rice,et al. Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and call for uniform reporting standards , 2008, PAIN.
[7] N. Laird,et al. Meta-analysis in clinical trials revisited. , 2015, Contemporary clinical trials.
[8] A B Haidich,et al. Meta-analysis in medical research. , 2010, Hippokratia.
[9] Andrew W. Brown,et al. Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry , 2017, BMJ Open.
[10] Jessica Gurevitch,et al. Meta-analysis and the science of research synthesis , 2018, Nature.
[11] Matthew Michelson,et al. A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study , 2018, Journal of medical Internet research.
[12] Van Norman Ga. Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs. , 2016 .
[13] Jop Vrieze. Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy , 2018, Science.
[14] Matthew Michelson. Automating Meta-Analyses of Randomized Clinical Trials: A First Look , 2014, AAAI Fall Symposia.
[15] Suhail A R Doi,et al. Meta-analysis of heterogeneous clinical trials: an empirical example. , 2011, Contemporary clinical trials.
[16] Steven Minton,et al. AI2 LEVERAGING MACHINE-ASSISTANCE TO REPLICATE A SYSTEMATIC REVIEW , 2019, Value in Health.
[17] R. Day,et al. No evidence or no alternative? Taking responsibility for off‐label prescribing , 2012, Internal medicine journal.
[18] Ethan M Balk,et al. A Web-based archive of systematic review data , 2012, Systematic Reviews.
[19] W. Bretz,et al. Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.
[20] G. Norman,et al. Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices , 2016 .
[21] D. Altshuler,et al. Validating therapeutic targets through human genetics , 2013, Nature Reviews Drug Discovery.
[22] Seema Rawat,et al. Publish or perish: Where are we heading? , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[23] Laura A. Levit,et al. Finding what works in health care : standards for systematic reviews , 2011 .
[24] Ewoud Schuit,et al. Network meta-analyses performed by contracting companies and commissioned by industry , 2016, Systematic Reviews.
[25] Malcolm Macleod,et al. How can we improve the pre-clinical development of drugs for stroke? , 2007, Trends in Neurosciences.
[26] Evans Whitaker. UCSF Guides: Systematic Review: When will I be finished? , 2015 .
[27] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[28] M. Ghert,et al. Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.